**Core Concept**
Mycobacterial infections, such as tuberculosis (TB), are caused by Mycobacterium species, which are resistant to many antibiotics due to their unique cell wall structure and drug efflux pumps. Effective treatment requires the use of specific antibiotics that can penetrate the bacterial cell wall and inhibit essential cellular processes.

**Why the Correct Answer is Right**
The correct answer is a drug that is not commonly used for treating mycobacterial infections. *Isoniazid* (Option A) is a first-line treatment for TB, working by inhibiting the synthesis of mycolic acid, an essential component of the mycobacterial cell wall. *Rifampicin* (Option B) is another first-line drug that inhibits RNA synthesis by binding to the beta-subunit of RNA polymerase. *Ethambutol* (Option C) is a first-line drug that inhibits arabinosyl transferase, an enzyme essential for cell wall synthesis.

**Why Each Wrong Option is Incorrect**
**Option D:** *Ciprofloxacin* is a fluoroquinolone antibiotic that is effective against a wide range of bacterial infections, but it is not typically used for treating mycobacterial infections due to its poor penetration into the bacterial cell and the development of resistance.

**Clinical Pearl / High-Yield Fact**
Mycobacterial infections require prolonged treatment regimens, often lasting 6-12 months or longer, to ensure clearance of the bacteria and prevent the development of resistance.

**Correct Answer:** D. Ciprofloxacin